Literature DB >> 15247001

Acute coronary syndrome, comorbidity, and mortality in geriatric patients.

E Taneva1, V Bogdanova, N Shtereva.   

Abstract

Morbidity and mortality rates from heart diseases are highly represented in geriatric-aged patients, but these patients also have supporting diseases. Acute coronary syndrome includes unstable angina and acute myocardial infarction with and without ST elevation. The aim of this study was to make a retrospective morbidity analysis of patients admitted to the emergency department. The study is made for a period of three years (from 1998 to 2000). It includes 588 patients divided by age (395 were 65-75 years old; 193 were older than 75 years) and sex (there were 326 men and 262 women). Comorbidity and mortality were investigated. Patients with one, two, three, and more than three supporting diseases were 6.29%, 23.13%, 68.53%, and 2.04%, respectively, of the total number. The most frequent geriatric patients had heart failure, followed by endocrinological diseases (type 2 diabetes, obesity, struma), neurological diseases (insultus, paresis), and chronic kidney diseases (pielonephritis, nephrolithiasis). The combination of hypertension, heart failure, and type 2 diabetes had the highest comorbidity frequency. The mortality rate for 1998 was 8.81%, for 1999 7.74%, and for 2000 13.41%. The mortality rate at the first 12 hours at the beginning of the acute coronary syndrome was 66.6%. Geriatric patients suffer from many diseases, and at the beginning of the onset of acute coronary syndrome they have multiorganal failure. Elderly patients are a high-risk contingent in intensive coronary care units.

Entities:  

Mesh:

Year:  2004        PMID: 15247001     DOI: 10.1196/annals.1297.019

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  6 in total

Review 1.  [Polypharmacy is of major concern in cardiology].

Authors:  Peter Dovjak; Ulrike Sommeregger; Ronald Otto; Regina E Roller; Birgit Böhmdorfer; Bernhard Iglseder; Ursula Benvenuti-Falger; Monika Lechleitner; Markus Gosch
Journal:  Wien Med Wochenschr       Date:  2010-06

2.  Pharmacokinetic interaction study of ticagrelor and cyclosporine in healthy volunteers.

Authors:  Renli Teng; Mirjana Kujacic; Judith Hsia
Journal:  Clin Drug Investig       Date:  2014-08       Impact factor: 2.859

3.  A pharmacokinetic interaction study of ticagrelor and digoxin in healthy volunteers.

Authors:  Renli Teng; Kathleen Butler
Journal:  Eur J Clin Pharmacol       Date:  2013-06-09       Impact factor: 2.953

Review 4.  A comprehensive view of sex-specific issues related to cardiovascular disease.

Authors:  Louise Pilote; Kaberi Dasgupta; Veena Guru; Karin H Humphries; Jennifer McGrath; Colleen Norris; Doreen Rabi; Johanne Tremblay; Arsham Alamian; Tracie Barnett; Jafna Cox; William Amin Ghali; Sherry Grace; Pavel Hamet; Teresa Ho; Susan Kirkland; Marie Lambert; Danielle Libersan; Jennifer O'Loughlin; Gilles Paradis; Milan Petrovich; Vicky Tagalakis
Journal:  CMAJ       Date:  2007-03-13       Impact factor: 8.262

5.  Effect of the CYP3A inhibitors, diltiazem and ketoconazole, on ticagrelor pharmacokinetics in healthy volunteers.

Authors:  Renli Teng; Kathleen Butler
Journal:  J Drug Assess       Date:  2013-03-15

6.  Does depressed persons with non-cardiovascular morbidity have a higher risk of CVD? A population-based cohort study in Sweden.

Authors:  Aysha Almas; Jette Moller; Romaina Iqbal; Andreas Lundin; Yvonne Forsell
Journal:  BMC Cardiovasc Disord       Date:  2019-11-21       Impact factor: 2.298

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.